![]() fostering collaboration with stakeholders and enhancing communication of supply problems to EU citizens.improving sharing of information and best practices among EU regulatory authorities to better coordinate actions across the EU.encouraging best practices to prevent shortages. ![]() developing strategies to improve prevention and management of shortages caused by disruptions in the supply chain (for example developing guidance for companies on reporting of shortages).looking at ways to minimise supply disruptions and avoid shortages by facilitating approval and marketing of medicines using the existing regulatory framework (for example by work sharing and reduced timetables when possible).More information on these is available below under 'Crisis preparedness and management'. In contrast, the structures and processes that EMA set up for dealing with medicine shortages in accordance with the Regulation on EMA's Reinforced Role (Regulation (EU) 2022/123) are primarily focusing on activities related to crisis situations. This aims to streamline processes, ensure synergies and avoid duplication of work within the network. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |